Neogen CORP (NASDAQ: NEOG) disclosed that CEO Nassif Mikheal purchased 23 shares of the company’s common stock on February 17, 2026, at a reported price of $10.94 per share. The filing lists the total value of the transaction as $251. After the transaction, Mikheal is identified as indirectly owning 704 shares.
The filing includes language clarifying the reporting status of the trade. It states that the reporting person disclaims beneficial ownership of these securities, and that the report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. The filing also notes that the shares are owned by his son.
Company results and market reaction
Separately from the insider filing, Neogen reported second-quarter results for fiscal 2026 that topped consensus expectations. The company posted earnings per share of $0.10 versus an expected $0.03, and revenue of $224.7 million compared with the forecasted $208.12 million. The company attributed its outperformance largely to strength in its Food Safety segment.
Following the results, William Blair maintained a Market Perform rating on Neogen. Guggenheim adjusted its view by raising its price target to $12.00 from $8.00 and continued to assign a Buy rating to the stock. The company’s Food Safety performance was cited as a primary factor in these analyst reactions. The filing also indicates that Neogen raised its guidance going forward, a development that reinforced the positive responses from some market observers.
Clear summary
Nassif Mikheal reported a small, indirect purchase of Neogen stock on February 17, 2026, while the company announced fiscal second-quarter results that beat expectations on both earnings and revenue, driven by Food Safety segment growth. Analysts issued mixed responses, with one firm reiterating Market Perform and another increasing its price target and maintaining a Buy stance.
Key points
- Insider transaction - CEO Nassif Mikheal purchased 23 shares at $10.94 on February 17, 2026, totaling $251; he is listed as indirectly owning 704 shares.
- Earnings beat - Neogen reported EPS of $0.10 versus $0.03 expected and revenue of $224.7 million versus $208.12 million expected, driven primarily by the Food Safety segment.
- Analyst responses - William Blair kept a Market Perform rating, while Guggenheim raised its price target to $12.00 from $8.00 and kept a Buy rating; the company also raised its guidance.
Risks and uncertainties
- Limited signal from the insider purchase - the disclosed transaction totaled $251, which may constrain the weight investors place on the trade as an indicator of executive conviction.
- Ownership clarity - the reporting person explicitly disclaims beneficial ownership and the filing states the shares are owned by his son, introducing uncertainty about direct executive control of the disclosed holdings.
- Guidance details not specified - while the company raised its guidance, the filing and accompanying statements reported here do not provide the specific numeric revisions, leaving future expectations imprecise.
This report presents the transaction details and the company’s earnings data as disclosed in filings and public statements. It does not attempt to infer causation beyond the information provided in those disclosures.